Cargando…

JCV viruria associates with suboptimal recovery of kidney function three years after living kidney donation

INTRODUCTION: Few studies have investigated pre-donation factors that could affect renal recovery after living kidney donation (LKD). We retrospectively investigated the role of John Cunningham virus (JCV) infection and other pre-donation factors on the magnitude of kidney function decline after LKD...

Descripción completa

Detalles Bibliográficos
Autores principales: Querido, Sara, Ormonde, Carolina, Adragão, Teresa, Weigert, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518630/
https://www.ncbi.nlm.nih.gov/pubmed/35138324
http://dx.doi.org/10.1590/2175-8239-JBN-2021-0148
Descripción
Sumario:INTRODUCTION: Few studies have investigated pre-donation factors that could affect renal recovery after living kidney donation (LKD). We retrospectively investigated the role of John Cunningham virus (JCV) infection and other pre-donation factors on the magnitude of kidney function decline after LKD. METHODS: Urine JCV viral loads, glomerular filtration rate, and blood pressure were evaluated in 60 consecutive LK donors before donation. Suboptimal compensatory hypertrophy was defined as an eGFR <60% of the pre-donation eGFR. RESULTS: LKD (40% JCV infected) were followed for 3.2±1.6 years. No association was found between age, gender, and baseline hypertension with 1(st), 2(nd), 3(rd), and 4(th) years post-donation eGFR <60% of the pre-donation eGFR. Mean eGFR recovery at the 3(rd) year after donation was lower in JCV infected donors vs non-infected donors (61.8% vs 71.0%, p=0.006). CONCLUSION: We hypothesized that JCV could shift glomeruli into a hyperfiltration state before nephrectomy, modulating the magnitude of compensatory hypertrophy after donation. Conversely, JCV might curtail the ability of the remaining kidney to promote hyperfiltration. Longer follow up is needed to determine whether JCV viruria ultimately leads to lower eGFR over time or if it is a protective factor for the remaining kidney.